Table 1.
Patient characteristics
| Parameters | Values |
|---|---|
| Age in year (mean±SD) | 49.0±14.4 |
| Sampling time pre-tx, month (mean±SD) | 3.7±2.5 |
| Follow-up, month (mean±SD) | 81.2 ±35.3 |
| Gender, n (%) | |
| Male | 192 (64.0%) |
| Female | 108 (36.0%) |
| Race, n (%) | |
| Caucasian | 239 (79.7%) |
| African | 29 (9.6%) |
| Asian | 14 (4.7%) |
| Hispanic | 18 (6.0%) |
| No. of transplant, n (%) | |
| First | 259 (86.3%) |
| Second | 35 (11.7 %) |
| Third | 6 (2.0%) |
| Donation, n (%) | |
| Deceased | 147 (49.0%) |
| Living related | 84 (28.0%) |
| Living unrelated | 69 (23.0%) |
| Transfusion pre-Tx, (n %) | |
| Yes | 94 (31.3%) |
| No | 206 (68.7%) |
| Induction therapy, (n %) | |
| Yes | 84 (27.9%) |
| No | 216 (72.1%) |
| Cause of end-stage renal disease, n (%) | |
| Polycystic kidney | 36 (12.0%) |
| Focal Segmental Glomerulosclerosis (Primary) | 26 (8.7%) |
| IgA nephropathy | 39 (13.0%) |
| Type I diabetes mellitus | 28 (9.3%) |
| Hypertension | 21 (7.0%) |
| Obstructive/reflux uropathy/anatomical issues | 22 (7.3%) |
| Systemic lupus erythematosus | 6 (2.0%) |
| Immune complex disease | 29 (9.7%) |
| Congenital/hereditary disease | 18 (6.0%) |
| Interstitial nephritis | 23 (7.7%) |
| Focal Segmental Glomerulosclerosis (Secondary) | 12 (4.0%) |
| Type II diabetes mellitus | 25 (8.3%) |
| Others | 4 (1.3%) |
| Unknow | 11 (3.7%) |